A novel method for generation of signature networks as biomarkers from complex high throughput data.
about
A comprehensive functional analysis of tissue specificity of human gene expressionProteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunctionGene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaProteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancersFunctional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.Different microRNA profiles in chronic epilepsy versus acute seizure mouse models.Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MSNetwork analysis of human glaucomatous optic nerve head astrocytes.Data mining for gene networks relevant to poor prognosis in lung cancer via backward-chaining rule induction.Bimodal gene expression patterns in breast cancerMolecular targets for diabetes mellitus-associated erectile dysfunction.A comprehensive look at transcription factor gene expression changes in colorectal adenomas.Consistency of predictive signature genes and classifiers generated using different microarray platforms.Changes in hippocampal gene expression by 7-nitroindazole in rats submitted to forced swimming stress.Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.A decade of systems biologyA genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency.Glyoxalase-I is a novel prognosis factor associated with gastric cancer progressionConstructing endophenotypes of complex diseases using non-negative matrix factorization and adjusted rand index.Functional analyses of endometriosis-related polymorphisms in the estrogen synthesis and metabolism-related genes.Challenges of the information age: the impact of false discovery on pathway identification.Transcriptome-wide profiling and posttranscriptional analysis of hematopoietic stem/progenitor cell differentiation toward myeloid commitmentAre there any differences between features of proteins expressed in malignant and benign breast cancers?Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation.In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs.Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosisStable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus productionProteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells.Treatment of allergic rhinitis with acupoint herbal plaster: an oligonucleotide chip analysisHighly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.Computational prediction of human drug metabolism.Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patients.Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.Cell type-specific DNA methylation patterns in the human breastAdvancing signaling networks through proteomics.Genetic similarity of chromosome 6 between patients receiving hematopoietic stem cell transplantation and HLA matched sibling donors.Microarray labeling extension values: laboratory signatures for Affymetrix GeneChips
P2860
Q21245339-30A18F5D-6054-4C36-A3CF-F529C0BD3BAAQ24650943-656527ED-0E4C-49BB-9F95-7BB8AD693884Q28248800-42FFCD6D-EFBA-4661-AE07-8BA0697247C1Q28482357-E5D7FBDB-5933-44BA-AD2D-3981A293BE7EQ30388028-05212C70-BE72-4F87-B1FD-58FC8BCB13B2Q30496004-F0CA81C8-E391-4A4E-853D-188365C47F4DQ30617784-F6231DD8-0CCE-497E-87A5-8A31F27FED7BQ33419602-647FF2D9-4C4A-4D85-8A37-74967BA10E95Q33442021-A8275BE0-1414-459E-86EB-00282142BA12Q33448545-61E3D974-473C-4ADF-ABE1-9F77EB2FBCACQ33531526-F936B084-1EBB-498F-BDD2-5B2797F81E79Q33770111-2AF21960-4EAD-4EFD-B5AC-B070D93FC10BQ33831794-EF498932-EF75-4F6F-AC69-E1FB4EC7F822Q34059968-5CC288ED-E2EC-4D74-AD17-B2FD2106A6A5Q34091772-260E1447-EC0F-4EE4-8D2A-96EC62C88AADQ34091855-783C8CC7-C712-4716-82B5-B82B22CD1459Q34124493-93E28DDB-A4C8-4119-81B0-4BE75CA412B6Q34155401-E042D41C-619C-4ECF-985F-58244A221832Q34222449-C9FED396-E080-4CEE-A8E0-22BCFB6B8077Q34345506-FDD52375-C212-4304-8EF4-4EC69E72D60AQ34471798-0FF9C9EE-4824-4E44-98FF-1FFCDF4A1501Q34484822-B572F77C-7335-4DB6-B4A6-E4BA7AB1685AQ34530150-5D945CAE-C261-40BF-B471-8A3710BCA4F6Q34864350-DB60B827-62D0-40E3-9162-CC4CDF8E366BQ34986181-9C37A304-F4E7-4E4B-9536-F8703A8466CDQ35162539-4E687954-65EB-4D7C-B261-BB774C1E17DCQ35171639-25E82CA5-0F22-4FAA-83C8-DAF1AA28B173Q35474247-6249719D-FCEC-4E4B-8742-F8ACCD0F0CCEQ35878747-286DEC8B-9612-4348-ADBD-4733188A92A8Q35914539-2313EA4B-DD3B-4DA9-8EFA-9863E684D9E6Q36144131-B9AF00A3-D3A9-460C-A398-A8A3B66B3685Q36183205-3A14813E-CD90-40AA-9B52-D99E3B73AC26Q36517999-6B20FFA4-B72F-43C7-A6E1-559574B1432DQ36572605-A39EE39A-26C0-4301-84E8-1CCFE99DE1F8Q36677842-87277078-2E91-4D33-B3D6-063E79B3DC1CQ36866006-3AE65FAA-5B8A-402C-B45B-64C061D4DD31Q36869180-6F2BD798-E01A-4DF1-BC37-3AEFD218F33EQ36913070-464292D3-12EA-4A0F-9156-56FFA788B6FCQ37146048-D7D4F210-6394-475D-B653-DAA6368A7E42Q37181588-FB7BF2FD-7F5A-42B7-A388-B48C1A9008FC
P2860
A novel method for generation of signature networks as biomarkers from complex high throughput data.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A novel method for generation ...... complex high throughput data.
@ast
A novel method for generation ...... complex high throughput data.
@en
type
label
A novel method for generation ...... complex high throughput data.
@ast
A novel method for generation ...... complex high throughput data.
@en
prefLabel
A novel method for generation ...... complex high throughput data.
@ast
A novel method for generation ...... complex high throughput data.
@en
P2093
P1433
P1476
A novel method for generation ...... complex high throughput data.
@en
P2093
Andrej Bugrim
Tatiana Nikolskaya
Yuri Nikolsky
P356
10.1016/J.TOXLET.2005.02.004
P50
P577
2005-07-01T00:00:00Z